Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), an oncogenic fusion protein, has been demonstrated to central the pathogenesis of ALK-positive ALCL (ALK+ALCL) [26]. This evidence concerns the gene NPM1 and anaplastic large cell lymphoma.